Nanomedicine and the innate immune system: immunogenicity, nanoparticle-immune cell interactions and implications for cancer immunotherapy
Nanoparticles were initially considered inert carriers for therapeutic payloads. This view has evolved substantially, as a growing body of experimental and clinical evidence indicates that engineered nanoparticles act as active immunomodulators, engagi…